A STUDY OF VIA AND VILI AS A CERVICAL CANCER SCREENING METHOD

Abstract

Introduction: As per globocan 2020, 604100 new cases of cervical cancer were detected worldwide in 2020, and 341831 deaths were there due to this malignancy. About 90% of these cases are found in low and middle-income countries. Cervical cancer is the only female genital tract cancer which can be diagnosed and treated in precancerous state by simple screening techniques. VIA/VILI are cheap and noninvasive methods and can be done in a low-level health facility. More importantly, VIA and VILI provide instant results, and those eligible for treatment of the precancerous lesions can be treated immediately. This retrospective study Material And Methods: was carried out in a Gynecology clinic in district Shivpuri M.P. From 1 April 2019 to 31 march 2022. 450 patients were studied. A detailed history regarding name, age, residence, socio-economic status, parity, any previous study, and any allergy was enquired. All ndings of VIA and VILI-positive cases were carefully documented in the proforma. In this study visual inspection of the cervix was done in 450 cases and 59 biopsy specimens were sent. In this study most of the patients were between 21-40 ye Results: ars of age (40%), multipara (74.88%), of low socioeconomic background (50.66%), and most of them were from rural areas (64%). The most common presenting symptom was excessive vaginal discharge (58.88%) followed by abnormal bleeding (13.11%). (13.11%) cases were VIA positive and (10.44%) cases were both VIA/VILI positive. Biopsy was taken from 59 patients who were VIA positive, this test detected 5.55% (25 patients) of CIN I, 2% (9 patients) of CIN II, 1.77% (8 patients) of CIN III, and 0.22% (1 patient) cases of squamous cell carcinoma. W Conclusion: e found that VIA and VILI can be adopted as screening tools for the diagnosis of cervical lesions. Result and follow-up treatment can be provided in a single sitting hence fewer women are lost to follow-up.